Primary advanced pulmonary synovial sarcoma treated with a multidisciplinary approach.

Doxorubicin Eribulin Multimodal therapy Pazopanib Radiosurgery Synovial sarcoma

Journal

International cancer conference journal
ISSN: 2192-3183
Titre abrégé: Int Cancer Conf J
Pays: Singapore
ID NLM: 101734231

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 18 08 2019
accepted: 04 02 2020
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 8 4 2020
Statut: epublish

Résumé

A 61-year-old woman was referred to our hospital due to right chest pain. A huge, 13-cm-diameter tumor was detected in the right lower lobe. For diagnostic and treatment purposes, pneumonectomy was performed, and the tumor was diagnosed as advanced pulmonary synovial sarcoma (SS) with pleural metastasis, according to immunohistochemistry analysis. Due to recurrence with brain metastases, treatment sequence composed of radiosurgery, doxorubicin, eribulin, and pazopanib was selected. The patient died after a considerably long survival of 29 months after the first visit. This case suggests that multimodal treatment may provide prolonged survival even for patients with advanced SS.

Identifiants

pubmed: 32257757
doi: 10.1007/s13691-020-00399-2
pii: 399
pmc: PMC7109214
doi:

Types de publication

Case Reports

Langues

eng

Pagination

72-76

Informations de copyright

© The Japan Society of Clinical Oncology 2020.

Déclaration de conflit d'intérêts

Conflict of interestNo author has any conflict of interest to disclose.

Références

Cancer. 2008 Aug 1;113(3):573-81
pubmed: 18521899
Ann Diagn Pathol. 2014 Dec;18(6):369-80
pubmed: 25438927
Eur J Cancer. 2012 Dec;48(18):3448-55
pubmed: 22835783
Cancer. 1995 Jan 1;75(1 Suppl):191-202
pubmed: 8000996
Mod Pathol. 2014 Mar;27(3):390-5
pubmed: 24030747
Lancet. 2012 May 19;379(9829):1879-86
pubmed: 22595799
Lancet Oncol. 2015 Apr;16(4):406-16
pubmed: 25795406
J Orthop Sci. 2017 Jul;22(4):755-764
pubmed: 28601416
Am J Surg Pathol. 2007 Feb;31(2):240-6
pubmed: 17255769
BMC Med. 2017 Apr 10;15(1):78
pubmed: 28391775
Am J Clin Pathol. 1999 Nov;112(5):641-8
pubmed: 10549251
Asian Pac J Cancer Prev. 2013;14(9):5185-8
pubmed: 24175798
Clin Sarcoma Res. 2016 Jul 11;6:11
pubmed: 27403280
BMJ. 2010 Dec 29;341:c7170
pubmed: 21190968
Lancet. 2016 Apr 16;387(10028):1629-37
pubmed: 26874885
Surg Oncol Clin N Am. 2016 Oct;25(4):789-802
pubmed: 27591499
Hum Pathol. 2001 Jan;32(1):105-12
pubmed: 11172303

Auteurs

Yosuke Kagawa (Y)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Soichi Kitaguchi (S)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Hanae Konishi (H)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Kaori Hashimoto (K)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Osaki Norihito (O)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Tadashi Mizumoto (T)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Ryohei Nishino (R)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Fumihiro Sugahara (F)

Department of Respiratory Medicine, Hiroshima City Asa Citizens Hospital, 2-1-1 Kabe-Minami, Asa-kita-ku, Hiroshima, 731-0293 Japan.

Classifications MeSH